The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Cancer Policy

HHS plans agency-wide vaccine injury programs

One million never-smokers are now vaping in the UK, survey finds

Trump administration sends Medicare beneficiaries $90 checks ahead of midterm elections

NIH awards $237.5M to advance biomedical and behavioral research

Trump targets HHS in $810M appropriations clawback

Federal judge blocks Trump’s second attempt at imposing $100,000 fee for H1-B visas

Clinical Roundup

NCCN publishes guidelines for pediatric Ewing sarcoma

Number of patients oncologists treated with cell and gene therapy has doubled, physician survey finds

Current age-based genetic testing may miss majority of inherited gene variants, MSK-led study finds

TGen-led study lays groundwork for using cfDNA to monitor glioblastoma

Urine test may improve bladder cancer diagnosis and guide treatment decision, Stanford-led study finds

BOT+BAL yield three-year survival in 48% of patients with recurrent ovarian cancer, phase Ib study finds

In The Clinic
Regulatory News

MD Anderson study suggests psilocybin may prevent chemo-induced neuropathy
“Because it works in one neural system, you begin to wonder: Well, what about another?”

FreeGuest Editorial
Guest Editorial
Trials & Tribulations

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account